• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Rockley Photonics Demonstrates Compact 4-Kelvin Silicon Photonics Modulator Enabling Interconnect Technologies for Ultra-sensitive Image Detection and Sensing Devices

    11/16/22 9:05:00 AM ET
    $RKLY
    Semiconductors
    Technology
    Get the next $RKLY alert in real time by email

    - Groundbreaking technology supports infrared and hyperspectral image detection and sensing devices to view images more clearly, at longer distances, and in low-light situations.

    - In collaboration with UC Santa Barbara, experiment shows first-time demonstration of a compact (micron-sized), monolithic silicon photonic electro-absorption-modulator maintaining its performance down to 4 Kelvin (-269.15 Celsius), enabling transmission of signals at cryogenically cooled temperatures with a compact, photonic integrated circuit.

    - Rockley's technology platform allows detection and sensing devices to be smaller in size and weight, and lower in power consumption.

    Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced a groundbreaking 4-Kelvin performance demonstration with its monolithic silicon photonics electro-absorption modulator technology that is key to the development of next-generation cryogenic interconnect technology. This advancement is intended to enable ultra-sensitive image detection and sensing devices to view and capture images more clearly and at longer distances, as well as in low-light situations and enables these devices to have a significantly reduced size and weight.

    UC Santa Barbara's project utilizes Rockley's powerful technology and will potentially advance detection and sensing capabilities in devices for a range of applications that require ultra-sensitive sensors. Possible applications include infrared and hyperspectral imagers and cameras that are used for night and day surveillance, aerial search and rescue, environmental remote sensing and chemical detection, ultra-sensitive neutrino detectors in particle accelerators, as well as interconnects for quantum computers.

    The cryogenic modulation experiment showed that the strong modulation of Rockley's silicon photonics electro-absorption modulator at room temperature is maintained when it is cooled down to 4 Kelvin (-269.15 Celsius, -452.47 Fahrenheit) with almost no performance degradation. At these low temperatures, signal noise in camera detector arrays is reduced dramatically, resulting in increased sensitivity, and enabling devices or cameras to view clearer images and the ability to see longer distances and in low light. The ability of Rockley's platform to maintain good performance and capture data at this very low temperature means that Rockley's photonic integrated circuit technology can be used to make these ultra-sensitive detection devices smaller in size and weight, have a lower cost, and operate with lower power consumption.

    Rockley has collaborated with UC Santa Barbara to make this demonstration. UC Santa Barbara brings their renown expertise in photonics research to the collaboration by performing the experiment that showed that high-speed signals could be modulated and extracted out of a cryostat chamber at temperatures from room temperature down to 4 Kelvin with minimal degradation of performance. The results will be presented at IEEE's Photonics Conference on November 16 and subsequently published in the conference proceedings.

    "At UC Santa Barbara, our research is focused on closely integrating electronics and photonics to push the boundaries of speed and efficiency for the photonic links and optical networks that data centers, computers, and sensors depend upon to share and move data," said Clint Schow, professor and Vice Chair of Electrical and Computer Engineering at UC Santa Barbara. "We are excited to collaborate with Rockley Photonics because our work in transmitting signals via light at very low cryogenically cooled temperatures will enable new technology that significantly increases sensitivity in sensors, resulting in the ability for cameras and devices to capture images with increased clarity."

    "Rockley has been innovating in photonics technology for many years and I am not surprised that our pioneering work has generated interest from academic research and other industries beyond health monitoring and wearables," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley. "I envision our technology will have broader and important applications that will benefit organizations and individuals around the world."

    "The ability of Rockley's silicon photonics platform to capture data at 4 Kelvin with good performance will lead to technological advancements in image detection and sensors, including hyperspectral imagers and cameras that are used by the department of defense, defense and aerospace industry, NASA, and environmental agencies," said Aaron Zilkie, chief technology officer of Photonics at Rockley. "Our collaborative work with UC Santa Barbara has been key to show us how this technology has the potential to take image detection to the next level and dramatically improve these devices."

    More information about Rockley's digital health monitoring solution is available here: https://rockleyphotonics.com/healthcare-sensing/.

    About Rockley Photonics

    Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfolio of biomarkers. Rockley's ground-breaking end-to-end biosensing platform unlocks unique spectra-based biomarkers enabling insights into personal health and well-being. With next-generation biosensing platforms specifically designed for mobile health monitoring, Rockley is laying the foundation for a new generation of biomedical applications across multiple industries.

    To learn more about Rockley, visit rockleyphotonics.com.

    Cautionary Note Regarding Forward-Looking Statements

    Statements in this press release that are not historical facts constitute "forward-looking statements" for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding Rockley's future expectations, beliefs, plans, objectives, and assumptions regarding future events or performance. The words "accelerate," "advance," "anticipate," "believe," "can," "capability," "continue," "could," "develop," "enable," "enhance", "estimate," "eventual," "expand, "expect," "focus," "forward," "future," "goal," "ground-breaking" "intend," "may," "might," "opportunity," "outlook," "plan," "possible," "position," "potential," "predict," "project," "revolutionize," "seem," "should," "trend," "vision," "will," "would" or other terms that predict or indicate future events, trends, or expectations, and similar expressions or the negative of such expressions may identify forward-looking statements, but the absence of these words or terms does not mean that a statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, statements regarding the following: (a) possible applications for our technology and the extent to which we may pursue potential opportunities; (b) the extent to which our technology will lead to smaller devices with lower power consumption at a lower cost; and (c) the extent of any additional technology advances based on our platform.

    Forward-looking statements are subject to several risks, assumptions, and uncertainties (many of which are beyond Rockley's control) that may cause actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, assumptions, and uncertainties include, but are not limited to, the factors described under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2021, and in other documents we file with the Securities and Exchange Commission. If any of these risks or uncertainties materialize, or should any of these assumptions prove incorrect, actual results may differ materially from those discussed in or implied by these forward-looking statements. There can be no assurance that future developments affecting Rockley will be those that have been anticipated. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date hereof and Rockley does not intend to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005088/en/

    Get the next $RKLY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLY

    DatePrice TargetRatingAnalyst
    8/12/2022$6.00 → $2.00Outperform → Neutral
    Robert W. Baird
    3/9/2022$20.00 → $10.00Outperform
    Northland Capital Markets
    3/9/2022$6.00 → $5.00Neutral
    B of A Securities
    3/9/2022$15.00 → $8.00Buy
    Needham
    12/22/2021$14.00 → $6.00Buy → Neutral
    B of A Securities
    9/17/2021$14.00Buy
    B of A Securities
    9/9/2021$22.00Outperform
    Cowen
    9/7/2021$15.00Buy
    Needham
    More analyst ratings

    $RKLY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application

      Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023. About Rockley Photonics Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfo

      12/29/22 9:05:00 AM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

      Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange ("NYSE") on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance wit

      12/15/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Announces Promotion of Richard A. (Randy) Meier to Chief Executive Officer

      Rickman to serve as executive chair; Becker promoted to interim chief financial officer Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth. Effective immediately, Richard A. Meier has been appointed president and chief executive officer, and will join the board of directors. Dr. Andrew Rickman has resigned as chief executive officer and will take on the role of executive chairman of Rockley. Chad Becker wi

      12/12/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    SEC Filings

    See more
    • SEC Form 15-12G filed by Rockley Photonics Holdings Limited

      15-12G - Rockley Photonics Holdings Ltd (0001852117) (Filer)

      5/15/23 7:44:57 AM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form 10-K filed by Rockley Photonics Holdings Limited

      10-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)

      5/15/23 7:25:35 AM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Holdings Limited filed SEC Form 8-K: Bankruptcy or Receivership, Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits

      8-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)

      4/7/23 4:05:05 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Meier Richard A

      4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

      10/21/22 5:43:39 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form 3 filed by new insider Meier Richard A

      3 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

      10/21/22 5:22:44 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form 4 filed by Kuntz Richard

      4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

      8/31/22 6:59:56 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Rockley Photonics Holdings Limited (Amendment)

      SC 13G/A - Rockley Photonics Holdings Ltd (0001852117) (Subject)

      2/14/23 4:05:33 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form SC 13G filed by Rockley Photonics Holdings Limited

      SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)

      2/14/23 4:01:54 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form SC 13G filed by Rockley Photonics Holdings Limited

      SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)

      2/14/23 1:23:02 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Rockley Photonics downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Rockley Photonics from Outperform to Neutral and set a new price target of $2.00 from $6.00 previously

      8/12/22 7:29:27 AM ET
      $RKLY
      Semiconductors
      Technology
    • Northland Capital Markets reiterated coverage on Rockley Photonics Hldgs with a new price target

      Northland Capital Markets reiterated coverage of Rockley Photonics Hldgs with a rating of Outperform and set a new price target of $10.00 from $20.00 previously

      3/9/22 11:07:52 AM ET
      $RKLY
      Semiconductors
      Technology
    • B of A Securities reiterated coverage on Rockley Photonics Hldgs with a new price target

      B of A Securities reiterated coverage of Rockley Photonics Hldgs with a rating of Neutral and set a new price target of $5.00 from $6.00 previously

      3/9/22 10:40:09 AM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Leadership Updates

    Live Leadership Updates

    See more
    • Rockley Photonics Appoints Healthcare Industry Veteran Richard A. "Randy" Meier President and Chief Financial Officer

      Meier to focus on driving cash-efficient performance and enabling commercial production ramp Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced the appointment of Richard A. "Randy" Meier as president and chief financial officer (CFO), effective immediately. Meier will shape Rockley's financial and commercialization strategies, and lead its finance, supply chain, quality, regulatory and compliance functions. An accomplished finance and operations leader with a rich background in healthcare therapeutics and medical devices, Meier joins Rockley from Intersect ENT, a leading global ear

      10/20/22 9:37:00 AM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Names Nicolaus Henke to Board of Directors

      Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Nicolaus Henke to its board of directors. Dr. Henke will join the board as an independent director, effective February 16, 2022, and will serve on the Nominating & Corporate Governance Committee. "I am very pleased with the appointment of Nicolaus Henke to our board. He brings a wealth of practical experience which will have an immediate impact on Rockley," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley Photonics. "Throughout his career, Nico has advised top teams in leading health systems, medical device companies and pha

      2/16/22 9:05:00 AM ET
      $RKLY
      Semiconductors
      Technology
    • SpartanNash Announces Board Refreshment; Appoints Three New Independent Directors

      Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and

      2/7/22 8:15:00 AM ET
      $BALY
      $CLRM
      $HELE
      $NXGN
      Hotels/Resorts
      Consumer Discretionary
      Consumer Electronics/Appliances
      Industrials

    $RKLY
    Financials

    Live finance-specific insights

    See more
    • Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

      Additional capital raised through private placement Reduction in headcount and operating costs targets lower cash burn Advanced blood pressure biomarker by demonstrating promising intra-subject tracking against standard blood pressure cuff Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced its financial results for the third quarter ended September 30, 2022. During the quarter, the Company advanced its technology platform, Bioptx™, through several technical and clinical targets: Expanded Free-Living Human Study of Its B

      11/9/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Announces Date of Third Quarter 2022 Financial Results Release

      Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it plans to report its third quarter 2022 financial results after the market closes on Wednesday, November 9, 2022. The company also plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook. The conference call can be accessed by dialing 877-407-0832 from the United States or +1 201-689-8433 internationally, referencing Rockley Photonics. A live webcast and replay of the conference call can be accessed from the investor relations page on Rockley's website at investors.rockleyphotonics.com. Follo

      10/26/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Reports Second Quarter of Fiscal 2022 Financial Results

      Signs Supply Agreement and Receives First Commercial Purchase Order from Top-Tier Medtech Company for Bioptx™ Baseline Band, Targets Fourth Quarter to Begin Shipping Signs First Contract Research Organization Partnership to Develop and Evaluate Rockley's Bioptx™ Biomarker Sensing Platform for Use in Clinical Trials Bolsters Board of Directors and Establishes Scientific Advisory Board Rockley Photonics Holdings Limited (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. "I am proud of the progress we made in the second quarter. As we ramp towards commercial produc

      8/11/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology